Investigator Initiated Trials (IITs) play an important role in helping sponsor companies better understand their drugs. Such studies support the discovery of new applications for existing therapeutics that contribute to enhanced treatment options and promote better health outcomes for patients. However, managing these studies presents unique and complex clinical supply chain challenges.
In this case, one biotechnology company was supplying over twenty individual IIT programs with its drug. The programs were geographically dispersed, single-site operations, and each with a specific protocol to adhere to. Download the case study to find out how Almac Clinical Services helped this sponsor effectively manage drug supply for multiple IIT programs.